PDS Biotechnology Corporation (PDSB)
NASDAQ: PDSB · Real-Time Price · USD
0.7571
+0.0017 (0.23%)
At close: Nov 24, 2025, 4:00 PM EST
0.7571
0.00 (0.00%)
Pre-market: Nov 25, 2025, 5:38 AM EST
PDS Biotechnology Market Cap
PDS Biotechnology has a market cap or net worth of $41.43 million as of November 25, 2025. Its market cap has decreased by -65.70% in one year.
Market Cap
41.43M
Enterprise Value
33.20M
1-Year Change
-65.70%
Ranking
Category
Stock Price
$0.76
Market Cap Chart
Since March 18, 2019, PDS Biotechnology's market cap has decreased from $45.51M to $41.43M, a decrease of -8.97%. That is a compound annual growth rate of -1.39%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 24, 2025 | 41.43M | -32.06% |
| Dec 31, 2024 | 60.98M | -60.56% |
| Dec 29, 2023 | 154.61M | -58.92% |
| Dec 30, 2022 | 376.31M | 63.37% |
| Dec 31, 2021 | 230.35M | 383.52% |
| Dec 31, 2020 | 47.64M | 240.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 948.84B |
| Johnson & Johnson | 491.26B |
| AbbVie | 417.60B |
| UnitedHealth Group | 289.84B |
| AstraZeneca | 280.49B |
| Novartis AG | 243.93B |
| Merck & Co. | 242.64B |
| Abbott Laboratories | 222.77B |